The Gynecologic-Oncology Program at Dana-Farber/Brigham and Women's Cancer Center (DFBWCC) provides multidisciplinary diagnostic care and treatment for patients with gynecologic cancers including ovarian, endometrial, cervical, vulvar and vaginal cancers and gestational trophoblastic disease. The Gynecologic-Oncology Program at DF/BWCC unites specialists from one of the world’s leading cancer institutes with experts from our top-ranked hospital.
Our Gynecologic-Oncology Program team includes physician leaders in gynecology, surgical oncology, medical oncology, pathology and radiation oncology, working alongside nurses, geneticists, infertility specialists, sexual health specialists, pharmacists, social workers, nurses, palliative care specialists and researchers. The experts on our team continually collaborate with each other and with patients and families to ensure the best possible outcomes – medically, emotionally and spiritually.
We offer the most advanced approaches – from pathologists who are exclusively dedicated to diagnosing gynecologic cancer to surgical oncologists who are leading experts in minimally invasive surgical procedures, including robotic-assisted surgery. DF/BWCC was the first center in New England to treat endometrial cancer using robotic-assisted surgery.
Patients have access to a wide range of therapies, including proven chemotherapy treatments and targeted radiation options as well as complimentary therapies that relieve symptoms and side-effects. Our gynecologic oncology clinical trial program is one of the most active in the country, bringing promising new research treatments directly from the laboratory to patient care.